Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Ferrous aspartate is a small molecule iron supplement belonging to the class of organic compounds known as aspartic acid derivatives. It is used to treat or prevent iron deficiency, particularly in cases of anemia. Like other oral iron supplements, it works by providing elemental iron, which is essential for hemoglobin and myoglobin synthesis in the body. Hemoglobin carries oxygen through the blood to tissues and organs, while myoglobin helps muscle cells store oxygen. Ferrous aspartate may be prescribed when there is a need for increased iron intake due to conditions such as pronounced iron deficiency[1][2]. Its mechanism of action involves supplying bioavailable ferrous (Fe2+) ions that are absorbed from the gastrointestinal tract and incorporated into hemoglobin.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on ferrous aspartate.